呼吸道支架/肺支架的全球市場規模:各產品，各用途，各地區，範圍及預測

氣道支架/肺支架市場規模及預測

2024年氣道支架/肺動脈支架市場規模為8783萬美元，預計到2031年將達到1.4716億美元，2024年至2031年複合年增長率為6.68%，預計將會增長。全球氣道支架/肺動脈支架市場的推動因素包括：治療肺癌等疑難雜症的MIS（微創手術）需求不斷增加、公共和私人機構對非血管支架開發的研發投資不斷增加以及實際應用的需求增加。該研究報告對全球氣道支架/肺支架市場進行了全面評估。它對關鍵細分市場、趨勢、市場推動因素、阻礙因素、競爭格局以及在市場中發揮關鍵作用的因素進行了全面分析。

氣道支架/肺支架的全球市場定義

氣道支架/肺支架是由各種材料製成的支氣管內假體，可支撐空心管狀氣道結構並保持其通暢。氣道支架可以幫助防止腫瘤進展到氣道，幫助治癒或控制氣道瘻管，或對抗氣道壁阻塞和外部焦點。支架由多種材料製成，包括金屬和矽膠。它們有各種尺寸和形狀。支架的範圍從暫時到永久。當存在惡性和良性過程的混合時，進行氣道支架置入術。無論適應症如何，在支架置入之前，胸腔外科醫師或介入性肺科醫師必須確保患者不患有手術可逆的氣道疾病。如果支架放置導致病灶超出 4 公分（氣管切除術常用的限制），則尤其如此。

氣道支架的使用經常會引起一些胸腔外科醫師和介入病理學家的腸道反應。這種下意識的反應要不是過去災難性案例的結果，就是你的導師在你的心靈中根深蒂固的。這些病例需要準確解釋具體病例、特定患者可用的選擇以及現代氣道支架的生物材料和工程背後的硬數據。一般來說，在醫學上能夠接受外科手術以挽救良性或致命性疾病的患者不應接受受影響的人工氣道的放置。如果患者功能嚴重受損且預期壽命很短，也不應放置支架。

全球氣道支架/肺動脈支架市場概況

全球氣道支架/肺支架市場主要由用於治療肺癌、青光眼、慢性阻塞性肺病、中央氣道阻塞、氣喘等疑難雜症的MIS（微創手術）需求不斷增長所推動。一個主要因素。肺癌患者往往患有呼吸道疾病。根據《亞太癌症預防雜誌》報導，大約 30% 的肺癌患者會出現中央氣道阻塞 (CAO)，這會導致嚴重的呼吸道併發症。因此，氣道支架的撥款和使用顯著增加，並且預計未來將持續下去。公共和私人機構對非血管支架開發的開創性研發投資正在推動市場成長。例如，2020 年 1 月，美國 FDA 批准了一種 3D 列印氣道支架，其製造適合患者氣道。

此外，技術進步，例如開發創新支架，可以利用物聯網和數據科學等先進技術提供呼吸道即時數據，也正在推動全球氣道支架市場在估計期間的成長。可生物降解肺支架和藥物洗脫肺支架的改進也將擴大氣道支架的採用並促進市場成長。然而，與支架置入相關的併發症和幾種可用的替代療法可能會限制特定時期內的市場成長。此外，吸菸率也在下降，這也是市場的阻礙因素。

目錄

第1章 呼吸道支架/肺支架的全球市場:簡介

• 市場概要
• 調查範圍
• 前提條件

第2章 摘要整理

第3章 VERIFIED MARKET RESEARCH的調查手法

• 資料探勘
• 驗證
• 一次採訪
• 資料來源一覽

第4章 呼吸道支架/肺支架的全球市場展望

• 概要
• 市場動態
• 促進因素
• 阻礙因素
• 機會
• 波特的五力分析
• 價值鏈分析

第5章 呼吸道支架/肺支架的全球市場:各產品

• 氣管支架
• 喉支架

第6章 呼吸道支架/肺支架的全球市場:各用途

• 醫院
• 門診病人手術中心

第7章 呼吸道支架/肺支架的全球市場:各地區

• 北美
• 美國
• 加拿大
• 墨西哥
• 歐洲
• 德國
• 英國
• 法國
• 其他歐洲
• 亞太地區
• 中國
• 日本
• 印度
• 其他亞太地區
• 全球其他地區
• 南美
• 中東·非洲

第8章 呼吸道支架/肺支架的全球市場:競爭情形

• 概要
• 企業的市場排行榜
• 主要的開發策略

第9章 企業簡介

• Boston Scientific
• C.R. Bard
• Taewoong Medical
• Micro-Tech(南京市)
• Teleflex
• Merit Medical Systems
• Cook Group
• Novatech Sa
• Endo-Flex
• M.I. Tech
• Efer Endoscopy
• Fuji Systems
• Hood Laboratories

第10章 附錄

• 相關報告

Airway Stent/Lung Stent Market Size And Forecast

Airway Stent/Lung Stent Market size was valued at USD 87.83 Million in 2024 and is projected to reach USD 147.16 Million by 2031 , growing at a CAGR of 6.68% from 2024 to 2031. The Global Airway Stent/Lung Stent Market has witnessed strong growth owing to the increasing demand for MIS (Minimally Invasive Surgeries) for the treatment of persistent conditions such as lung cancer, growing R&D investments by the public and private organizations for the development of non-vascular stents, and technological advancements such as the development of innovative stents that can offer real-time data of the respiratory tract. The Global Airway Stent/Lung Stent Market report provides a holistic evaluation of the market. The report offers a comprehensive analysis of key segments, trends, drivers, restraints, competitive landscape, and factors that are playing a substantial role in the market.

Global Airway Stent/Lung Stent Market Definition

An airway/lung stent is an endobronchial prosthesis of different materials that supports and preserves the patency of the hollow tubular airway structure. An airway stent may prevent the extension of a tumor into the airway, may help in the healing or control of airway fistulas, or may help the airway wall against failure or external concentration. Stents can be made of various materials, such as metal or silicone. They also come in various sizes and shapes. They can be momentary or permanent. Airway stenting is shown in a mixture of malignant and benign processes. Independent of the indication, before any stent placement, the thoracic surgeon or interventional pulmonologist must be sure that the sufferer does not have any surgically reversible airway disease. Stenting may involve or preclude surgery in some cases, especially when it extends the lesion to >4 cm in length, a generally used limit for tracheal resection.

The use of airway stents often elicits a visceral reaction from some thoracic surgeons and interventional pulmonologists. These reflexive rejoinders are the result of catastrophic cases in the past or are strongly ingrained in their psyche by their instructors. When this occurs, it is necessary to accurately interpret the particular case, the possible options for that special patient, and the solid data behind the biomaterials and engineering of contemporary airway stents. In general, patients medically able to experience surgical interventions to preserve benign or deadly conditions should not have an affected airway prosthesis placed. Also, very close impairment in functional capacity and very short survival expectancy should preclude stenting.

What's inside a VMR industry report?

Our reports include actionable data and forward-looking analysis that help you craft pitches, create business plans, build presentations and write proposals.

Global Airway Stent/Lung Stent Market Overview

The Global Airway Stent/Lung Stent Market is principally driven by increasing demand for MIS (Minimally Invasive Surgeries) for the treatment of persistent conditions including lung cancer, glaucoma, chronic obstructive pulmonary disease, central airway obstruction, asthma, etc. Patients suffering from lung cancer are inclined to suffer from breathing conditions. According to the Asian Pacific Journal of Cancer Prevention, around 30% of the patients suffering from lung cancer occur central airway obstruction (CAO) which results in severe breathing complications. As a result, the appropriation and utilization of airway stents have increased significantly and are anticipated to follow a similar trend in the following years. Growing R&D investments by the public and private organizations for the development of non-vascular stents is besides fueling the market growth. For example, in January 2020, the U.S. FDA approved 3D printed airway stent, which is produced to fit the patient's airway.

Additionally, technological advancements such as the development of innovative stents that can offer real-time data of the respiratory tract using excellent technologies like IoT and Data Science are also adding to the growth of the global airway stenting market during the estimated timeframe. The improvement of biodegradable and drug-eluting lung stents will also expand the adoption of airway stents, thus augmenting the growth of the market. However, complications connected with stent implementation and several alternative treatments available might restrain the growth of the market during the given time frame. Moreover, the pervasiveness of tobacco smoking has also been decreasing, which also acts as a restraint to the market.

Global Airway Stent/Lung Stent Market Segmentation Analysis

The Global Airway Stent/Lung Stent Market Segmented On The Basis Of Product, Application, And Geography.

Airway Stent/Lung Stent Market, By Product

• Tracheal Stents
• Laryngeal Stents
• Bronchial Stents

Based on Product, the market is bifurcated into Tracheal Stents, Laryngeal Stents, and Bronchial stents. The bronchial stent segment is anticipated to grow at the highest CAGR during the forecast period owing to the high adoption of bronchial stents to treat respiratory disorders. Bronchial stents are additionally largely used in the treatment of hemoptysis following lung cancer and in the treatment of progressive dyspnea therefore, there is an enhanced demand for bronchial stents. Furthermore, bronchial stents are favored due to requirements such as palliative relief of symptoms, minimal invasiveness, and decreased chances of risks in surgeries.

Airway Stent/Lung Stent Market, By Application

• Hospitals
• Ambulatory Surgery Centers

Based on Application, the market is bifurcated into Hospitals and Ambulatory Surgery Centers. The Ambulatory Surgery Centers segment is estimated to witness the highest CAGR for the forecast period. Ambulatory surgical centers are more cost-effective than conventional hospitals and provide a shorter duration of stay post-surgery. Moreover, an increment in several ambulatory surgical centers and a rise in choice for minimally invasive surgeries are further factors enlarging the demand for lung stents.

Airway Stent/Lung Stent Market, By Geography

• North America
• Europe
• Asia Pacific
• Rest of the world.

Based on regional analysis, the Global Airway Stent/Lung Stent Market is classified into North America, Europe, Asia Pacific, and the Rest of the world. The North American airway stent market is estimated for the largest revenue share as of 2019 and it is anticipated to maintain its dominance during the forecast period. The presence of significant manufacturers, well-established healthcare infrastructure, and high awareness amongst the doctors ended in the rising adoption of these stents in this region. Moreover, the rising prevalence of diseases, growing geriatric population, and rising healthcare expenditure are also contributing to the growth of the market in this region.

Key Players

• The "Global Airway Stent/Lung Stent Market" study report will provide valuable insight with an emphasis on the global market. The major players in the market are
• Boston Scientific, C.R. Bard, Taewoong Medical, Micro-Tech (Nanjing), Teleflex, Merit Medical Systems, Cook Group, Novatech Sa, Endo-Flex, M.I. Tech, Ever Endoscopy, Fuji Systems, Hood Laboratories

Our market analysis also entails a section solely dedicated to such major players wherein our analysts provide an insight into the financial statements of all the major players, along with its product benchmarking and SWOT analysis. The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.

TABLE OF CONTENTS

1. Introduction of Global Airway Stent/Lung Stent Market

• Overview of the Market
• Scope of Report
• Assumptions

2. Executive Summary

3. Research Methodology of Verified Market Research

• Data Mining
• Validation
• Primary Interviews
• List of Data Sources

4. Global Airway Stent/Lung Stent Market Outlook

• Overview
• Market Dynamics
• Drivers
• Restraints
• Opportunities
• Porters Five Force Model
• Value Chain Analysis

5. Global Airway Stent/Lung Stent Market, By Product

• Tracheal Stents
• Laryngeal Stents

6. Global Airway Stent/Lung Stent Market, By Application

• Hospitals
• Ambulatory Surgery Centres

7. Global Airway Stent/Lung Stent Market, By Geography

• North America
• U.S.
• Canada
• Mexico
• Europe
• Germany
• UK
• France
• Rest of Europe
• Asia Pacific
• China
• Japan
• India
• Rest of Asia Pacific
• Rest of the World
• Latin America
• Middle East & Africa

8. Global Airway Stent/Lung Stent Market Competitive Landscape

• Overview
• Company Market Ranking
• Key Development Strategies

9. Company Profiles

• Boston Scientific
• C.R. Bard
• Taewoong Medical
• Micro-Tech (Nanjing)
• Teleflex
• Merit Medical Systems
• Cook Group
• Novatech Sa
• Endo-Flex
• M.I. Tech
• Efer Endoscopy
• Fuji Systems
• Hood Laboratories

10. Appendix

• Related Reports